Replies to post #258 on SurModics Inc (SRDX)

[DewDiligence]

>…more or less optimistic about this company's prospects than they were 2-3 years ago?<

I initially became more optimistic when SRDX announced a major move into ophthalmology. (I had posted on the Yahoo board long before SRDX announced the ophthalmology initiative that I was hoping the company would become a player in the burgeoning AMD arena.)

However, I am now somewhat more pessimistic because I don’t see the InnoRx platform as a serious rival to ordinary (intravitreal) Lucentis. I’m now in “show me” mode with respect to SRDX’s ophthalmology program: until I see evidence to the contrary, I’m inclined to think that the company’s effort is too little too late. JMHO, FWIW

[foolishpremise]

More optimistic overall.

I started investing in SRDX purely as a DES play - but the company continues to both forge excellent relationships and diversify their technology offerings (ECM modified ultraweb for instance) in a manner I find quite reasuring. I'm in for the long hall.

[aslan2772]

SRDX board and outlook. I really enjoy reading and posting on this board as well. I'm glad to see so many thoughtful and polite people migrate together from the Yahoo site.

My personal outlook for SRDX is that they are still compellingly undervalued relative to their potential. The stock is perhaps less attractive today than it was a couple of years ago at the low $20s/share, but still a compelling investment in the 30's IMHO. At the moment I'm basically sitting on my shares waiting for SRDX technology to ripen, having made some new investments in GTCB (thanks Dew). SRDX is still my largest of 4 holdings. GTCB is my second largest.